Business Standard

Monday, December 23, 2024 | 11:23 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covaxin's final product has no calf serum, Bharat Biotech and govt clarify

Health ministry says this has been used for decades in Polio, Rabies, and Influenza vaccines, is neither used in growth of SARS CoV2 virus nor in the final formulation

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Ruchika ChitravanshiSohini Das New Delhi/Mumbai
The Government on Wednesday clarified that Bharat Biotech’s Covaxin does not contain newborn calf serum at all and that the calf serum is not an ingredient of the final vaccine product. Amid the controversy, Bharat Biotech also clarified that new born calf serum is used in the manufacturing of viral vaccines.

A Health ministry statement explained that the newborn calf serum is used for preparation and growth of vero cells which are used in production of vaccines. This technique has been used for decades in Polio, Rabies, and Influenza vaccines.

“It is used for the growth of cells, but neither

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in